| Drug Name: | Isoflurane (26675-46-7) |
|---|---|
| PubChem ID: | 3763 |
| SMILES: | C(C(F)(F)F)(OC(F)F)Cl |
| InchiKey: | PIWKPBJCKXDKJR-UHFFFAOYSA-N |
| Therapeutic Category: | Anesthetics, Central Nervous System Agents, Central Nervous System Depressants |
| Molecular Weight (dalton) | : | 184.491 |
| LogP | : | 2.3528 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 9.23 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Doxorubicin (23214-92-8) | Pr Prolongation | Antagonistic | Uncertain | Is prolongation of the QTc interval during isoflurane anaesthesia more prominent in women pretreated with anthracyclines for breast cancer? |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category